Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Operating Leases (2020 - 2025)

Bio Essence has reported Operating Leases over the past 6 years, most recently at $1.5 million for Q4 2025.

  • Quarterly results put Operating Leases at $1.5 million for Q4 2025, up 282.37% from a year ago — trailing twelve months through Dec 2025 was $1.5 million (up 282.37% YoY), and the annual figure for FY2025 was $1.5 million, up 282.37%.
  • Operating Leases for Q4 2025 was $1.5 million at Bio Essence, up from $99668.0 in the prior quarter.
  • Over the last five years, Operating Leases for BIOE hit a ceiling of $1.6 million in Q3 2023 and a floor of $99668.0 in Q2 2025.
  • Median Operating Leases over the past 5 years was $952756.0 (2022), compared with a mean of $919099.4.
  • Peak annual rise in Operating Leases hit 282.37% in 2025, while the deepest fall reached 85.18% in 2025.
  • Bio Essence's Operating Leases stood at $1.1 million in 2021, then fell by 15.15% to $952756.0 in 2022, then dropped by 1.51% to $938409.0 in 2023, then tumbled by 58.2% to $392290.0 in 2024, then soared by 282.37% to $1.5 million in 2025.
  • The last three reported values for Operating Leases were $1.5 million (Q4 2025), $99668.0 (Q2 2025), and $247164.0 (Q1 2025) per Business Quant data.